Back

Outcomes for haemorrhagic transformation patients treated with left atrial appendage occlusion

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Left atrial appendage closure Left Atrial Appendage Closure EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Avi Sabbag

Chaim Sheba Medical Center, Ramat Gan (Israel)

6 More presentations in this session

Presentation thumbnail
Risk of cerebrovascular events in patients after left atrial appendage closure: results from large, real-world dataset
Doctor A. Maan (Toledo, US)
Abstract Slides Video
Presentation thumbnail
Application of deep learning models to transesophageal echocardiography images for percutaneous left atrial appendage closure
Doctor R. Tateishi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Temporal morphological changes of the left atrial appendage after electrical isolation: implications for optimal timing of LAA occlusion
Doctor M. Tanaka (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Mechanical thrombus aspiration as a bailout strategy for device related thrombus after LAAC
Doctor V. La Fazia (Austin, US)
Abstract Slides Video
Presentation thumbnail
Clinical practice in left atrial appendage closure with focus on antithrombotic therapy: results from a European Heart Rhythm Association survey
Doctor L. Urbanek (Frankfurt, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Left atrial appendage closure

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Role of left atrial appendage occlusion versus direct oral anticoagulants in elderly patients (>80 years) with atrial fibrillation: a retrospective cohort analysis
thumbnail
Congress Presentation
Percutaneous left atrial appendage occlusion versus direct oral anticoagulation therapy in clinical practice: a propensity-score matched study
thumbnail
Congress Presentation
Left atrial appendage occlusion should always be considered: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources